Clinical Cancer Research (CCR)
Journal Descriptions
Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, molecular alterations and biomarkers that predict response or resistance to treatment. The Journal will consider laboratory and animal studies of new drugs and molecularly-targeted agents that are approved for clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. Specific areas of interest include clinical research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; antibody-based therapy; cellular and gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; innovative imaging and other novel methods with applicability to clinical investigation; clinical genetics; detection of minimal residual disease; and clinical artificial intelligence.
Clinical Cancer Research (CCR) is :-
-
International, Peer-Reviewed, Open Access, Refereed, pharmacology, animal studies, Cancer, drug sensitivity, Clinical Oncology, Translational Medicine, Molecular Biology, Cancer Biology, Pharmacology, Biomarker Research , Online or Print , Bi-Weekly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1078-0432, E-ISSN: 1557-3265, Established: 1995, Impact Factor: 10.2
- Provides Crossref DOI
-
Indexed in: Scopus, WoS, PubMed
-
Not indexed in DOAJ, UGC CARE
